Valeo Pharma Inc (VPH.CX)

0.93 +0.00  +0.00% CNSX Oct 23, 20:00 CAD

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.valeopharma.com
  • Investor Relations URL: N/A
  • HQ State/Province: Quebec
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: N/A
  • Next Earnings Release: N/A
  • Last Earnings Release: N/A
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Valeo Pharma Inc a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: branded prescription products and niche hospital injectable products. Its products include Benztropine, Synacthen, M-Eslon, and among others.

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.